sarscov
sarsassoci
coronaviru
report
novel
viru
member
coronaviru
famili
caus
sever
acut
respiratori
syndrom
coronaviru
replic
occur
uniqu
mechan
employ
leader
sequenc
transcript
initi
transcript
genom
therefor
clone
leader
sequenc
sarscov
ident
identifi
sarscov
construct
specif
sirna
target
leader
sequenc
use
egfp
rfp
report
gene
fuse
clone
sarscov
leader
sequenc
demonstr
sirna
target
leader
sequenc
decreas
mrna
abund
protein
express
level
report
gene
cell
stabli
express
sirna
vero
cell
provid
data
sirna
could
effect
specif
decreas
mrna
abund
sarscov
gene
analyz
rtpcr
northern
blot
data
indic
sirna
target
leader
sequenc
inhibit
replic
sarscov
vero
cell
silenc
gene
express
demonstr
via
transient
transfect
experi
sirna
target
leader
sequenc
much
stronger
inhibitori
effect
sarscov
replic
sirna
target
spike
gene
antisens
oligodeoxynucleotid
report
provid
evid
target
leader
sequenc
use
sirna
could
power
tool
inhibit
sarscov
replic
gene
therapi
sarscov
sarsassoci
coronaviru
pathogen
sever
acut
respiratori
syndrom
sar
report
novel
member
coronaviru
famili
coronavirus
belong
famili
envelop
virus
contain
singlestrand
plussens
rna
genom
kb
length
cap
structur
polyadenyl
tract
addit
genom
rna
virusinfect
cell
possess
subgenom
mrna
form
cotermin
nest
set
genom
genom
subgenom
mrna
coronavirus
includ
ident
leader
sequenc
common
end
uniqu
characterist
coronaviru
arteriviru
replic
process
coronaviru
replic
leader
sequenc
subgenom
fuse
mrna
bodi
sequenc
mechan
subgenom
mrna
made
fulli
understood
howev
recent
evid
indic
transcriptionregul
sequenc
trss
end
gene
repres
signal
regul
discontinu
transcript
subgenom
mrna
nevertheless
leader
sequenc
trss
play
critic
role
gene
express
coronaviru
replic
analysi
comparison
genom
sequenc
sarscov
coronavirus
author
predict
confirm
put
leader
sequenc
similar
conserv
coronaviru
core
leader
sequenc
end
genom
put
conserv
tr
sequenc
aaac
gaaac
determin
manual
align
sequenc
upstream
potenti
initi
methionin
codon
region
coronaviru
genom
sequenc
contain
leader
sequenc
predict
suggest
sarscov
possess
similar
genom
structur
underw
similar
replic
process
typic
coronavirus
therefor
interest
search
way
block
viru
replic
base
common
featur
coronaviru
rnai
technolog
approv
potenti
tool
inhibit
infecti
viru
host
cell
sirna
target
silenc
import
gene
requir
viru
attempt
inhibit
viru
replic
author
demonstr
sirna
could
effect
inhibit
polioviru
rou
sarcoma
viru
replic
furthermor
block
hiv
replic
infect
sirna
design
target
critic
gene
hiv
life
cycl
includ
hiv
longtermin
repeat
vif
nef
tat
rev
result
show
promis
inhibit
effect
viru
cell
cultur
mous
model
use
methodolog
sirna
use
inhibit
hepat
c
hcv
hepat
b
hbv
replic
target
critic
gene
requir
viru
replic
combin
result
promis
sinc
show
inhibit
viral
replic
cell
cultur
well
mous
model
recent
studi
shown
sirna
could
inhibit
gene
express
therebi
inhibit
replic
sarscov
cultur
cell
howev
report
focus
specif
gene
sarscov
genom
would
high
probabl
singl
nucleic
acid
chang
lead
reduc
effect
sirna
target
therefor
choos
uniqu
sequenc
sarscov
genom
critic
success
inhibit
viru
report
propos
target
leader
sequenc
sarscov
ident
sarscov
play
pivot
role
gene
express
viru
demonstr
sirna
gener
could
effect
specif
silenc
gene
express
inhibit
sarscov
replic
cultur
mammalian
cell
data
provid
possibl
way
use
gene
therapi
sar
clone
leader
sequenc
design
sirna
base
high
homolog
genom
sequenc
sarscov
genbank
access
number
mous
hepat
viru
identif
leader
sequenc
predict
ident
leader
sequenc
sar
cov
data
shown
clone
leader
sequenc
predict
sar
cov
perform
race
experi
confirm
leader
sequenc
use
rtpcr
obtain
cdna
transcript
differ
gene
sarscov
infect
vero
cell
sequenc
observ
ident
leader
sequenc
upstream
atg
differ
gene
figur
genbank
access
number
suggest
transcript
differ
gene
sarscov
recruit
ident
leader
sequenc
consist
report
data
indic
transcript
protein
contain
leader
sequenc
directli
upstream
atg
transcript
protein
differ
nucleotid
base
atg
conserv
leader
sequenc
eg
protein
base
pair
figur
intriguingli
leader
sequenc
highli
conserv
differ
strain
sarscov
sequenc
code
specif
protein
n
e
contain
variou
mutat
differ
strain
tabl
accord
inform
sequenc
ccaaccaacctcgatctc
select
design
sirna
target
proper
gcat
ratio
cc
structur
gener
dsrna
base
sequenc
employ
promot
vector
construct
bp
sirna
hairpin
figur
expect
hairpin
rna
depict
figur
leader
sequenc
test
vectorbas
sirna
design
could
silenc
express
gene
leader
sequenc
use
gfp
rfp
report
gene
insert
leader
sequenc
sarscov
upstream
first
atg
gfp
promot
figur
data
indic
gener
gfp
rfp
mrna
sarscov
leader
sequenc
vector
either
cmv
promot
rtpcr
result
show
cmv
promot
initi
transcript
mrna
gfp
rfp
sarscov
leader
sequenc
figur
question
whether
mrna
could
translat
gfp
rfp
protein
test
probabl
directli
test
express
gfp
rfp
use
fluoresc
microscop
cell
transfect
vector
data
show
four
vector
could
express
gfp
rfp
properli
figur
suggest
leader
sequenc
ahead
atg
gfp
rfp
affect
translat
protein
therefor
directli
observ
protein
produc
mrna
leader
sequenc
vector
therefor
provid
us
model
studi
degrad
mrna
use
leader
sequenc
sarscov
target
sirna
data
suggest
sirna
target
leader
sequenc
sarscov
specif
led
decreas
mrna
level
lgfp
lrfp
gener
pefbo
vector
impli
sirna
target
leader
sequenc
mediat
degrad
mrna
produc
transfect
vector
advantag
use
gfp
rfp
facil
direct
observ
protein
fluoresc
microscopi
demonstr
decreas
lgfp
mrna
produc
less
protein
appli
fluoresc
microscopi
view
cell
cotransfect
pefbo
use
pcr
verifi
clone
contain
cassett
figur
cell
clone
name
vero
vero
vero
gfprnai
respect
demonstr
sirna
could
reduc
mrna
abund
differ
gene
sarscov
cultur
cell
infect
cell
clone
sarscov
pfuwel
h
h
harvest
cell
detect
differ
gene
transcript
use
rtpcr
shown
figur
sarscovinfect
vero
vero
vero
cell
show
equal
amount
mrna
wherea
sarscovinfect
vero
lrnai
cell
show
signific
decreas
mrna
figur
quantifi
result
scan
densiti
band
data
present
figur
figur
clearli
demonstr
sirna
target
leader
sequenc
significantli
inhibit
gene
express
detect
gene
includ
e
n
gene
sarscov
confirm
rtpcr
result
perform
northern
blot
analysi
use
total
rna
isol
infect
cell
two
titer
sarscov
infect
success
detect
five
major
transcript
figur
consist
expect
result
quantit
five
transcript
use
phosphorimag
program
figur
data
indic
mrna
cell
sirna
target
leader
sequenc
significantli
decreas
figur
compar
lane
lane
lane
lane
expect
taken
togeth
data
demonstr
sirna
design
could
effect
decreas
express
gene
sarscov
cultur
cell
determin
whether
vectorbas
sirna
could
effici
prevent
sarscov
replic
infect
plate
cell
plate
densiti
cellswel
infect
cell
pfu
sarscov
h
cultur
demonstr
inhibit
sarscov
stain
cell
crystal
violet
figur
result
show
cell
infect
sarscov
exhibit
greater
resist
viru
infect
vero
lrnai
cell
stain
strongli
noninfect
cell
figur
plate
vero
vero
vero
cell
stain
equal
weakli
plate
demonstr
cell
destruct
furthermor
view
cell
morpholog
chang
figur
signific
cytopath
effect
seen
plate
vero
wildtyp
cell
vero
cell
vero
cell
figur
sirna
target
leader
sequenc
effect
inhibit
sarscov
replic
sirna
target
gene
antisens
oligodeoxynucleotid
previous
report
sirna
target
gene
could
inhibit
sarscov
replic
therefor
question
whether
sirna
target
leader
sequenc
effect
target
specif
gene
compar
effect
use
amount
plasmid
transfect
vero
cell
measur
viru
titer
supernat
cell
infect
amount
sarscov
data
figur
replic
dramat
interestingli
compar
control
viru
titer
cell
transfect
suggest
much
stronger
inhibitori
effect
viru
replic
address
whether
antisens
effect
viru
replic
gener
antisens
oligodeoxynucleotid
directli
synthes
oligodeoxynucleotid
transfect
amount
oligodeoxynucleotid
mg
dna
plate
data
cultur
data
figur
show
one
antisens
oligodeoxynucleotid
could
inhibit
viru
two
effect
inhibit
viru
data
clearli
indic
target
leader
sequenc
could
strongli
inhibit
sarscov
replic
vero
cell
sar
emerg
one
newest
sever
infecti
diseas
threaten
global
travel
signific
econom
impact
variou
countri
caus
novel
coronaviru
sar
treat
tradit
antiviru
drug
although
interferon
may
use
therapi
addit
strategi
control
diseas
postul
vaccin
potenti
best
approach
vaccin
develop
take
least
one
sever
year
even
though
expect
vaccin
develop
altern
therapeut
method
need
investig
report
investig
possibl
appli
sirna
target
leader
sequenc
sarscov
treat
sar
demonstr
method
power
inhibit
sarscov
replic
inhibit
gene
express
viru
cell
report
togeth
other
hiv
hcv
hbv
provid
hope
directli
block
viru
replic
cell
sarsassoci
coronaviru
classifi
novel
number
coronaviru
famili
structur
viru
similar
coronavirus
contain
e
n
protein
play
import
role
viral
entri
replic
pathogenesi
common
featur
coronavirus
similar
discontinu
transcript
subgenom
mrna
regul
pretranscrib
leader
sequenc
specif
trss
genom
viru
leader
sequenc
contribut
regul
viru
gene
express
therefor
target
leader
sequenc
present
mrna
sarscov
structur
gene
power
way
control
viru
replic
interestingli
analyz
strain
sarscov
identifi
date
found
leader
sequenc
remain
almost
ident
see
tabl
advantag
design
sirna
target
leader
sequenc
sarscov
data
show
sirna
could
block
express
report
gene
fuse
leader
sequenc
also
inhibit
express
sarscov
gene
vero
cell
thereaft
inhibit
replic
sarscov
vero
cell
propos
would
power
tool
prevent
sarscov
infect
vivo
previous
suggest
coronaviru
use
core
leader
sequenc
report
clone
transcript
four
gene
sarscov
confirm
sarscov
leader
sequenc
ccaggaaaagccaaccaacctcga
tctcttgtagatctgttctctaaacgaac
line
report
strain
observ
reveal
leader
sequenc
ident
present
differ
gene
sarscov
data
indic
sequenc
ident
leader
sequenc
atg
differ
transcript
variabl
gene
space
common
leader
sequenc
atg
gene
longest
spacer
sequenc
impli
common
leader
sequenc
differ
merg
site
sequenc
differ
gene
sarscov
importantli
observ
leader
sequenc
ident
differ
strain
sarscov
identifi
date
tabl
sequenc
sarscov
show
variat
evalu
effici
sirna
use
gfp
rfp
report
gene
fuse
leader
sequenc
sarscov
prove
mrna
fuse
leader
sequenc
affect
translat
gfp
rfp
protein
cultur
cell
expect
data
show
sirna
could
block
express
report
gene
leader
sequenc
effect
without
leader
sequenc
consist
result
obtain
direct
observ
gfp
rfp
protein
use
fluoresc
microscopi
western
blot
analysi
simpl
observ
model
use
show
effect
sirna
transcript
gene
leader
sequenc
laboratori
previous
report
use
sirna
target
gene
sarscov
inhibit
viru
replic
probabl
gene
variat
gene
might
caus
randomli
select
target
sequenc
chang
would
reduc
effect
design
sirna
leader
sequenc
coronaviru
remain
ident
postul
gener
sirna
target
leader
sequenc
sarscov
necessari
transcript
variou
gene
viru
consid
target
site
power
target
individu
gene
would
overcom
variou
mutat
gene
sarscov
theori
complet
knock
one
gene
lead
blockad
viru
replic
howev
empir
sirna
could
knock
express
target
gene
express
therefor
design
sirna
target
sever
gene
provid
better
inhibit
viru
replic
aim
leader
sequenc
sarscov
provid
use
target
part
mrna
gene
critic
sarscov
replic
inde
experi
show
sirna
target
leader
sequenc
effect
sirna
gene
also
data
indic
sirna
target
leader
sequenc
power
compar
antisens
oligodeoxynucleotid
might
sever
reason
lower
effect
antisens
oligodeoxynucleotid
includ
lower
transfect
effici
di
li
et
al
gestion
dnase
lower
transcript
antisens
mrna
nucleu
conclus
report
sirna
target
leader
sequenc
sarscov
could
effect
inhibit
gene
express
replic
viru
cultur
cell
work
provid
base
gene
therapi
sar
whether
adenoviru
deliveri
system
could
use
therapi
sar
anim
model
human
need
investig
sequenc
sarscov
clone
genbank
access
number
use
predict
leader
sequenc
base
leader
sequenc
similar
coronaviru
famili
base
inform
predict
primer
design
amplifi
cdna
transcript
differ
gene
sarscov
rtpcr
product
sequenc
primer
use
forward
locat
upstream
common
leader
sequenc
sarscov
ccaggaaaagccaac
caac
revers
locat
differ
gene
sarscov
gene
ccatgcatagacagaagggaa
gene
ttactgtactagcaaagcaa
e
gene
tta
gaccagaagatcagga
n
gene
tgcctgagtt
gaatcagc
n
gene
common
genom
sequenc
gctattaaaatcacatgggga
end
gene
rna
transcript
identifi
use
endswitch
race
commerci
kit
smart
race
cdna
amplif
kit
total
rna
mg
extract
virusinfect
vero
cell
use
race
reaction
accord
manufactur
instruct
specif
primer
gct
locat
near
end
possibl
gene
use
pcr
primer
forward
revers
use
nest
pcr
locat
target
site
sirna
sarscov
leader
sequenc
select
sequenc
bp
structur
agn
tt
empir
design
chose
site
gcat
ratio
match
criteria
uniqu
specif
target
sequenc
ccaaccaacctcgatctc
determin
sequenc
confirm
specif
blast
nr
human
genom
databas
synthes
oligo
forward
ccaac
caacctcgatctcttcaagagagagatcgaggttg
revers
aattcaaaaagc
caaccaacctcgatctctctcttgaagagatcgag
vector
vector
construct
antisens
rna
synthesi
backbon
vector
promot
kindli
provid
dr
yang
shi
use
construct
sirna
vector
hairpin
cdna
gener
anneal
complementari
oligo
synthes
directli
insert
vector
apai
ecori
site
correct
clone
verifi
kpni
xhoi
cut
final
clone
confirm
sequenc
vector
name
construct
report
vector
sarscov
leader
sequenc
pefbosgfp
vector
use
backbon
subclon
kpni
bamhi
site
insert
sarscov
leader
sequenc
cdna
gener
anneal
complementari
oligo
synthes
sens
cccaggaaaagc
caaccaacctcgatctcttgtagatctgttctctaa
antisens
gatccgttcgtttaga
gaacagatctacaagagatcg
aggttggttggctt
correct
clone
verifi
kpni
bamhi
cut
gener
bp
insert
clone
sequenc
confirm
two
report
vector
leader
sequenc
sarscov
name
pefboslgfp
l
stand
leader
sequenc
correct
express
mrna
construct
examin
rtpcr
use
primer
shown
figur
sarscov
leader
sequenc
forward
primer
ccaggaaaagccaac
caa
b
gfp
forward
primer
atggtgagcaagggc
ga
c
gfp
revers
primer
ttacttgtacagct
cgtccatg
rfp
forward
primer
atggtgcgctc
ctccaa
e
rfp
revers
primer
ctacaggaa
caggtggtgg
vector
use
paper
includ
pb
construct
lab
gfprnai
kindli
provid
dr
yang
shi
establish
stabl
cell
line
base
vero
cell
use
backbon
subclon
insert
spei
ecori
site
vector
promot
gfprnai
lrnai
sequenc
three
new
construct
name
lrnai
antisens
oligodeoxynucleotid
target
differ
region
sarscov
leader
sequenc
directli
synthes
thiomodifi
sequenc
use
three
well
repeat
use
experi
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
uml
penicillin
mgml
streptomycin
cell
plate
sixwel
dish
densiti
cell
well
cultur
overnight
transfect
total
mg
dnawel
use
transfect
calpho
clontech
transfect
reagent
accord
manufactur
protocol
case
largescal
transfect
vero
cell
plate
mm
dish
densiti
cellsdish
total
mg
dnawel
use
transfect
calpho
clontech
transfect
cell
cultur
least
h
longer
experi
antisens
oligodeoxynucleotid
transfect
plate
densiti
cellswel
total
mg
dnawel
lipofectamin
construct
transfect
vero
cell
select
mgml
week
singlecel
clone
transfect
construct
select
amplifi
correct
clone
examin
pcr
use
genom
dna
clone
cell
pcr
primer
use
forward
revers
agaac
final
experi
sar
infect
least
three
clone
mix
pool
repres
clone
recombin
fragment
also
name
cell
line
establish
genom
dna
total
rna
cell
extract
use
trizol
invitrogen
respect
addit
rnaas
dnaas
pcr
reaction
perform
use
primer
indic
experi
pcr
reaction
condit
describ
figur
legend
rtpcr
carri
use
one
step
rna
rtpcr
kit
takara
japan
mg
total
rna
sampl
accord
manufactur
protocol
sarscov
strain
genbank
access
number
provid
beij
institut
microbiolog
epidemiolog
aimm
china
propag
vero
cell
viru
releas
infect
cell
three
cycl
freez
thaw
test
inhibit
viru
sirna
cell
stabl
cell
line
plate
infect
pfu
sarscov
final
volum
ml
dmem
fb
h
cell
wash
phosphatebuff
salin
pb
ph
ad
ml
complet
media
ad
allow
growth
h
co
differ
sarscov
infect
experi
ratio
cellviru
use
oper
perform
biosafeti
level
lab
vero
cell
plate
challeng
seri
dilut
sampl
viru
viru
allow
infect
cell
h
complet
withdrawn
wash
pb
incub
h
cell
stain
dilut
infect
cell
stain
regard
titer
viru
pfu
detect
gfp
protein
fuse
sarscov
leader
sequenc
cell
harvest
h
posttransfect
lyse
ml
cold
lysi
buffer
mm
triscl
ph
mm
nacl
mm
edta
triton
na
vo
mm
sodium
pyrophosph
mm
bglycerolphosph
mm
pmsf
mgml
aprotinin
mgml
leupeptin
ph
mg
total
cell
lysi
protein
per
sampl
separ
sdspage
electrotransf
nitrocellulos
membran
hybon
eci
amersham
pharmacia
biotech
v
h
follow
western
blot
analysi
antibodi
directli
gfp
bactin
obtain
santa
cruz
ca
usa
signal
detect
enhanc
chemiluminesc
ecl
amersham
total
rna
mg
differ
cell
infect
sarscov
subject
formaldehydeagaros
gel
transfer
nitrocellulos
membran
probe
sarscov
label
p
use
primeagen
kit
promega
accord
manufactur
protocol
hybrid
perform
h
hybrid
butter
promega
membran
wash
ssc
sd
three
time
autoradiograph
phosphorimag
dna
storm
amersham
pharmacia
biotech
probe
use
gener
digest
n
gene
cdna
use
ecori
correspond
end
sar
genom
day
transfect
report
construct
cell
harvest
analyz
aid
fluoresc
microscop
leica
deerfield
il
usa
use
object
data
acquir
soni
digit
chargecoupl
devic
camera
process
adob
photoshop
softwar
cell
infect
sarscov
stain
min
ml
violet
stain
solut
mg
crystal
violet
ml
ethanol
plu
ml
dh
wash
min
ml
destain
solut
ethanol
acet
acid
dh
cell
morpholog
observ
use
microscopi
experi
report
gene
express
cell
directli
observ
nikon
fluoresc
microscop
pictur
taken
ccd
camera
spot
diagnost
instrument
inc
usa
equip
computerbas
imag
acquisit
system
